Table 1

Baseline characteristics, cardiovascular risk factors and history stratified by clinical indication

Stable CAD (n=352)NSTEACS (n=88)Overall (n=440)
Age (years)69.3 (62.9–75.1)71 (63.4–77.4)69.6 (63–75.8)
Female, n (%)71 (20)27 (31)98 (22)
BMI (kg/m2)26.2 (24.2–28.9)27 (24.6–30)26.3 (24.2–29.3)
Creatinine (mg/dL)0.9 (0.79, 1.08)0.97 (0.85, 1.18)0.91 (0.8, 1.10)
SYNTAX score12 (8–20)15 (8–20)13 (8–20)
CV risk factors
 Diabetes, n (%)173 (49)43 (49)216 (49)
 Hypertension, n (%)262 (75)71 (78)333 (75)
 Dyslipidaemia, n (%)190 (54)48 (55)238 (54)
 Active smoker, n (%)53 (15)16 (18)69 (16)
 Prior smoker, n (%)85 (24)13 (15)98 (22)
 History of premature CAD, n (%)99 (28)19 (22)118 (27)
History
 Prior angina, n (%)250 (71)52 (59)302 (69)
 Prior MI, n (%)95 (27)20 (23)115 (26)
 Prior PCI, n (%)148 (42)28 (32)176 (40)
 Renal insufficiency, n (%)38 (11)20 (23)58 (13)
 Heart failure, n (%)14 (4)2 (2)16 (4)
 LVSD, n (%)23 (7)8 (9)31 (7)
 COPD, n (%)26 (7)8 (9)34 (8)
 Stroke, n (%)18 (5)5 (6)23 (5)
 PAD, n (%)55 (16)10 (11)65 (15)
  • BMI, body mass index; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CV, cardiovascular; LVSD, left ventricular systolic dysfunction defined as ejection fraction of 0.40 or less; MI, myocardial infarction; NSTEACS, non-ST elevation acute coronary syndrome; PAD, peripheral artery disease; PCI, percutaneous coronary intervention; SYNTAX, SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery.